{"title":"Dosimetric impact of dose constraint indications using individual patient dose management system for brachytherapy in cervical cancer.","authors":"Takahito Chiba, Satoshi Nakamura, Hiroki Nakayama, Kotaro Iijima, Shuka Nishina, Naoya Murakami, Jun Takatsu, Ayaka Nagao, Tairo Kashihara, Kae Okuma, Kana Takahashi, Koji Inaba, Tomoya Kaneda, Hiroshi Igaki, Atsushi Myojoyama, Hiroyuki Okamoto","doi":"10.5114/jcb.2025.153918","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Total dose assessment for cervical cancer necessitates converting external beam radiotherapy (EBRT) and brachytherapy (BT) doses to equivalent doses in 2 Gy fractions (EQD<sub>2</sub>), and compare them with dose constraints. However, this feature is absent in current treatment planning systems. To address this, we developed a system fulfilling this need, and evaluated its dosimetric impact.</p><p><strong>Material and methods: </strong>The system can assess total dose by considering EQD<sub>2</sub> for targets and organs at risk (OARs), and provide ideal fractionated dose that satisfies dose constraints in each process. The current retrospective study included 82 cervical cancer patients treated with EBRT and four BT fractions. Forty-one patients were assigned to either of two groups (with or without system). These groups were compared with typical dosimetry parameters (DPs) for high-risk clinical target volume (HR-CTV), rectum, bladder, and percentage of dose constraint achievement of DPs to reveal dosimetric impact of the system. Sub-group analysis included 61 patients with HR-CTV doses of < 85 Gy to examine whether treatment planning was adequate with or without the system.</p><p><strong>Results: </strong>The DP for HR-CTV was similar across BTs, but for OARs, it was statistically significantly lower in the group with system (<i>p</i> < 0.001) than in the other group. Also, the group with system had a higher percentage of cases meeting HR-CTV dose constraints (<i>p</i> = 0.02), with no variation in OARs. Sub-group analysis revealed better adherence to dose constraints in the group with system for each BT compared with the other group.</p><p><strong>Conclusions: </strong>System usage would facilitate a balanced plan, increasing clinical target volume coverage as much as possible, while considering dose constraints of OARs.</p>","PeriodicalId":51305,"journal":{"name":"Journal of Contemporary Brachytherapy","volume":"17 4","pages":"255-266"},"PeriodicalIF":1.1000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12489536/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Contemporary Brachytherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5114/jcb.2025.153918","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/29 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: Total dose assessment for cervical cancer necessitates converting external beam radiotherapy (EBRT) and brachytherapy (BT) doses to equivalent doses in 2 Gy fractions (EQD2), and compare them with dose constraints. However, this feature is absent in current treatment planning systems. To address this, we developed a system fulfilling this need, and evaluated its dosimetric impact.
Material and methods: The system can assess total dose by considering EQD2 for targets and organs at risk (OARs), and provide ideal fractionated dose that satisfies dose constraints in each process. The current retrospective study included 82 cervical cancer patients treated with EBRT and four BT fractions. Forty-one patients were assigned to either of two groups (with or without system). These groups were compared with typical dosimetry parameters (DPs) for high-risk clinical target volume (HR-CTV), rectum, bladder, and percentage of dose constraint achievement of DPs to reveal dosimetric impact of the system. Sub-group analysis included 61 patients with HR-CTV doses of < 85 Gy to examine whether treatment planning was adequate with or without the system.
Results: The DP for HR-CTV was similar across BTs, but for OARs, it was statistically significantly lower in the group with system (p < 0.001) than in the other group. Also, the group with system had a higher percentage of cases meeting HR-CTV dose constraints (p = 0.02), with no variation in OARs. Sub-group analysis revealed better adherence to dose constraints in the group with system for each BT compared with the other group.
Conclusions: System usage would facilitate a balanced plan, increasing clinical target volume coverage as much as possible, while considering dose constraints of OARs.
期刊介绍：
The “Journal of Contemporary Brachytherapy” is an international and multidisciplinary journal that will publish papers of original research as well as reviews of articles. Main subjects of the journal include: clinical brachytherapy, combined modality treatment, advances in radiobiology, hyperthermia and tumour biology, as well as physical aspects relevant to brachytherapy, particularly in the field of imaging, dosimetry and radiation therapy planning. Original contributions will include experimental studies of combined modality treatment, tumor sensitization and normal tissue protection, molecular radiation biology, and clinical investigations of cancer treatment in brachytherapy. Another field of interest will be the educational part of the journal.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
